Home › Free Stock Grades › ARDX
Ardelyx, Inc. (ARDX) Stock Grade
ARDX · Healthcare
C
Market Cap
$842.4M
P/E Ratio
—
Revenue Growth (YoY)
+22.1%
Net Margin
-15.1%
Return on Equity
—
Dividend Yield
None
About Ardelyx, Inc.'s fundamentals
Ardelyx is a biotechnology company with a market capitalization of $842.4 million that has demonstrated strong revenue growth of 22.1% year-over-year, indicating expanding commercial traction. However, the company operates at a net loss, with a negative net margin of -15.1%, reflecting typical early-stage biotech economics where sales have not yet reached profitability levels. The company does not pay a dividend, which is common for loss-making biotech firms that prioritize reinvestment in research and development activities.